Dnanexus, Inc. was awarded a firm fixed price delivery order valued at one hundred ninety-four thousand five hundred ninety-eight dollars and thirteen cents ($194,598.13) by the Department of Health and Human Services' Food and Drug Administration (FDA). This delivery order, with a period of performance through September 2023 and no set-aside designation, is issued against Dnanexus' twenty million dollar ($20M) indefinite delivery contract for ongoing provision of the FDA's PrecisionFDA...
This $1,134,088.88 firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. to provide a Common Data Harmonization System FIDLE Integration. The contract has a period of performance through March 31, 2024 and is not set aside. Dnanexus, a for-profit organization, has a history of supporting FDA initiatives like the PrecisionFDA program, providing cloud-based bioinformatics tools and genomic analysis platform services to the regulatory...
Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...
The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...
The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported...
The Department of Health and Human Services Food and Drug Administration awarded a $2.8 million firm fixed price delivery order contract to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will deliver its cloud-based precisionFDA platform to support the FDA's regulatory science programs over a one year period of performance ending in September 2022. No subcontractors or set aside designations were identified. This contract leverages Dnanexus' existing...
This federal contract award to DnaNexus, Inc., doing business as DnaNexus Inc., is a $240,904.24 firm-fixed-price delivery order for the operation and maintenance of the U.S. Food and Drug Administration's (FDA) PrecisionFDA public instance of the Global Submission Registry System (GSRS). The contract has a period of performance through May 31, 2025 and was awarded on June 3, 2024. This award is not associated with a set-aside program. DnaNexus is a for-profit organization that has previously...
This is a $1,051,402.26 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. for the development of a PRISM high-impact platform pilot to support pre-submission validation of electronic common technical documents (eCTDs) and sponsor-reviewer interaction. The contract has an ultimate completion date of September 9, 2025. Dnanexus is a for-profit cloud-based genomics data management and analysis services provider that has previously supported the...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed-price purchase order contract to Dnanexus, Inc. for a "Biobank Research Analysis Platform." The $12,569.50 contract does not have a set-aside designation and is for the delivery of cloud-based genomics data management and analysis services from Dnanexus, a for-profit organization. Through this award, Dnanexus will provide bioinformatics software,...